CD86 and hepatocellular carcinoma: Despite M2 macrophages’ similar tumor-promoting role, Rnaseh2c-cKO did not affect M1 (CD80, CD86) or M2 (CD163, ARG1) marker expression in mouse HCC-infiltrating macrophages (Fig. 1H, I).